Document 2306 DOCN M94A2306 TI AIDS/HIV projection and optimal intervention strategies. DT 9412 AU McGrail LM; Moy EV SO Int Conf AIDS. 1994 Aug 7-12;10(1):334 (abstract no. PC0269). Unique Identifier : AIDSLINE ICA10/94370269 AB OBJECTIVE: To develop, for any geographical area, a method of calculating the optimal allocations of resources for the prevention of the spread of HIV. METHODS: Using easily understood discrete-time compartment models, projection of the spread of the HIV/AIDS epidemic is discussed. The concept of mathematically modeling interventions in the epidemic is introduced. Intervention models are combined with epidemic models in such a way that interventions can be viewed as controls of the epidemic. Discrete-time optimal-control theory is reviewed and used to calculate an optimal distribution of interventions for a given criterion and this distribution is referred to as an optimal intervention strategy. Example problems are formulated and solved with an eye to suggesting applications of this theory. RESULTS: Proper selection of optimality criteria enables, for a given geographic area, calculation of: the optimal distribution of intervention programs for a given total cost of interventions; or the optimal total cost and distribution of interventions to minimize the total cost, or total health care cost, of the epidemic; or the optimal total cost and distribution of interventions to reduce the loss of human life to a certain level. Applications to the calculation of optimal vaccination or cure administration schedules are also suggested. DISCUSSION: The method presented can be adapted to unexpected contingencies and can be combined with economic models and models of other diseases to form more comprehensive policy recommendations. DE Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/*PREVENTION & CONTROL Cost-Benefit Analysis Disease Outbreaks/*STATISTICS & NUMER DATA Economics Forecasting Health Care Rationing/*ECONOMICS Health Policy/ECONOMICS Human HIV Infections/EPIDEMIOLOGY/*PREVENTION & CONTROL HIV Seroprevalence/*TRENDS Models, Statistical MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).